Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

TVF Communications

- PMLiVE

Merck and Astellas/Pfizer’s bladder cancer combination receives MHRA approval

About 614,000 people are diagnosed with bladder cancer globally every year

- PMLiVE

PM Society Awards 2025 open for entries

The ceremony will be held at JW Marriott Grosvenor House in London on 14 March

- PMLiVE

Behavioural Data Offering from Medscape Global

See more about this new insights product, Medscape AffinityTM, which offers unparalleled insights into the online behaviour of 13M+ HCPs to help you make fully informed decisions around your brand and content...

Medscape Medical Affairs

- PMLiVE

Ipsen’s Iqirvo approved by MHRA to treat primary biliary cholangitis in adults

Approximately 25,000 people in the UK are affected by the rare liver disease

- PMLiVE

PMLiVE’s T40 – results announced!

The list highlights the creative agencies that had the most impact on the UK healthcare sector in 2023

- PMLiVE

Merck’s Keytruda shows promise as perioperative head and neck cancer treatment

More than 58,450 new cases of the disease are expected to be diagnosed in the US this year

- PMLiVE

Astellas and AviadoBio enter exclusive dementia gene therapy deal worth over $2bn

Frontotemporal dementia accounts for less than one in 30 cases of the neurodegenerative disorder

- PMLiVE

Merck and Mestag enter inflammatory disease partnership worth up to $1.9bn

The agreement will see Mestag use its platform designed to model the pathogenic role of fibroblasts

- PMLiVE

FREE Origins Webinar: How Patient Involvement is Transforming Clinical Trials – Reserve Your Spot Today!

Only one week to go until our highly anticipated webinar: “Why Patient Perspectives Matter: Driving Success in Clinical Trials”!   We’re thrilled to have Wendy Erler and Alfred Samuels joining...

Origins – The Patient Focused Specialists

- PMLiVE

Navigating US payer evidence needs to optimise market access

What clinical and economic evidence do US payers prefer to drive formulary decisions? How can you optimise your chances of preferential access in the US with the right evidence? How...

Petauri Evidence

- PMLiVE

AstraZeneca/Avillion share positive phase 3 results for asthma rescue treatment Airsupra

The chronic respiratory disease is estimated to affect up to 262 million people globally

- PMLiVE

J&J’s Erleada shows overall survival benefit in head-to-head prostate cancer study

Approximately 300,000 new cases of the disease are diagnosed in the US every year

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links